You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新華醫療(600587.SH):擬受讓新華印尼公司51%股權的出資權
格隆匯 06-05 15:44

格隆匯6月5日丨新華醫療(600587.SH)公佈,公司全資子公司Karlmed GmbH擬受讓自然人Verdy Kohar、Michael Ellyeser Patty合計持有的新華醫療(印度尼西亞)有限公司(“新華印尼公司”)51%股權的出資權,並履行出資義務。

新華印尼公司成立於2017年9月,其註冊資本為100萬美元,其中公司全資子公司華佗國際發展有限公司認繳出資49萬美元,佔其註冊資本的49%;自然人Verdy Kohar認繳出資26萬美元,佔其註冊資本的26%;自然人Michael Ellyeser Patty認繳出資25萬美元,佔其註冊資本的25%。其主營業務為醫療器械、實驗室設備等批發銷售。

此次交易完成後,新華印尼公司將成為公司的全資子公司,納入公司財務報表合併範圍,有利於公司深入拓展印度尼西亞市場,提高市場佔有率,符合公司和全體股東的利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account